{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:24:06Z","timestamp":1770485046171,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T00:00:00Z","timestamp":1376352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12094-013-1077-2","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T09:15:52Z","timestamp":1376298952000},"page":"322-329","source":"Crossref","is-referenced-by-count":21,"title":["Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours"],"prefix":"10.1007","volume":"16","author":[{"given":"I.","family":"Dur\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Garc\u00eda-Carbonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"P\u00e9rez-Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. \u00c1.","family":"Segu\u00ed-Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Restovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Gasquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,13]]},"reference":[{"issue":"Suppl 4","key":"1077_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","volume":"9","author":"RE Coleman","year":"2004","unstructured":"Coleman RE. Bisphosphonates: clinical experience. Oncologist. 2004;9(Suppl 4):14\u201327.","journal-title":"Oncologist."},{"issue":"Suppl 1","key":"1077_CR2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.breast.2004.09.004","volume":"13","author":"RE Coleman","year":"2004","unstructured":"Coleman RE. The role of bisphosphonates in breast cancer. Breast. 2004;13(Suppl 1):S19\u201328.","journal-title":"Breast."},{"issue":"7","key":"1077_CR3","first-page":"341","volume":"4","author":"T Delea","year":"2006","unstructured":"Delea T, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, et al. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol. 2006;4(7):341\u20137.","journal-title":"J Support Oncol."},{"issue":"2","key":"1077_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11864-005-0023-0","volume":"6","author":"A Lipton","year":"2005","unstructured":"Lipton A. Management of bone metastases in breast cancer. Curr Treat Options Oncol. 2005;6(2):161\u201371.","journal-title":"Curr Treat Options Oncol"},{"issue":"4 Suppl 11","key":"1077_CR5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0093-7754(01)90228-3","volume":"28","author":"P LoRusso","year":"2001","unstructured":"LoRusso P. Analysis of skeletal-related events in breast cancer and response to therapy. Semin Oncol. 2001;28(4 Suppl 11):22\u20137.","journal-title":"Semin Oncol"},{"issue":"3","key":"1077_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165\u201376.","journal-title":"Cancer Treat Rev"},{"key":"1077_CR7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2407-9-272","volume":"9","author":"PP Major","year":"2009","unstructured":"Major PP, Cook RJ, Lipton A, Smith MR, Terpos E, Coleman RE. Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity. BMC Cancer. 2009;9:272.","journal-title":"BMC Cancer."},{"issue":"6","key":"1077_CR8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3816\/CGC.2007.n.022","volume":"5","author":"F Saad","year":"2007","unstructured":"Saad F, Chen YM, Gleason DM, Chin J. Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases. Clin Genitourin Cancer. 2007;5(6):390\u20136.","journal-title":"Clin Genitourin Cancer."},{"issue":"3","key":"1077_CR9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3816\/CLC.2004.n.030","volume":"6","author":"V Hirsh","year":"2004","unstructured":"Hirsh V, Tchekmedyian NS, Rosen LS, Zheng M, Hei YJ. Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications. Clin Lung Cancer. 2004;6(3):170\u20134.","journal-title":"Clin Lung Cancer."},{"issue":"1","key":"1077_CR10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cncr.11892","volume":"100","author":"LS Rosen","year":"2004","unstructured":"Rosen LS, Gordon DH, Dugan W Jr, Major P, Eisenberg PD, Provencher L, et al. Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion. Cancer. 2004;100(1):36\u201343.","journal-title":"Cancer"},{"issue":"2","key":"1077_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.1995.03520260051032","volume":"273","author":"MS Litwin","year":"1995","unstructured":"Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273(2):129\u201335.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"1077_CR12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000474402","volume":"24","author":"H Villavicencio","year":"1993","unstructured":"Villavicencio H. Quality of life of patients with advanced and metastatic prostatic carcinoma. Eur Urol. 1993;24(Suppl 2):118\u201321.","journal-title":"Eur Urol"},{"issue":"2","key":"1077_CR13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.mlr.0000108746.69256.45","volume":"42","author":"KP Weinfurt","year":"2004","unstructured":"Weinfurt KP, Castel LD, Li Y, Timbie JW, Glendenning GA, Schulman KA. Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions. Med Care. 2004;42(2):164\u201375.","journal-title":"Med Care"},{"issue":"4","key":"1077_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/annonc\/mdi122","volume":"16","author":"KP Weinfurt","year":"2005","unstructured":"Weinfurt KP, Li Y, Castel LD, Saad F, Timbie JW, Glendenning GA. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol. 2005;16(4):579\u201384.","journal-title":"Ann Oncol"},{"issue":"2","key":"1077_CR15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3816\/SCT.2007.n.003","volume":"4","author":"A Lipton","year":"2007","unstructured":"Lipton A. Treatment of bone metastases and bone pain with bisphosphonates. Support Cancer Ther. 2007;4(2):92\u2013100.","journal-title":"Support Cancer Ther."},{"issue":"6","key":"1077_CR16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2354.2009.01135.x","volume":"19","author":"RD Pockett","year":"2010","unstructured":"Pockett RD, Castellano D, McEwan P, Oglesby A, Barber BL, Chung K. The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. Eur J Cancer Care (Engl). 2010;19(6):755\u201360.","journal-title":"Eur J Cancer Care (Engl)."},{"key":"1077_CR17","doi-asserted-by":"crossref","first-page":"e16523","DOI":"10.1200\/jco.2011.29.15_suppl.e16523","volume":"29","author":"A Bahl","year":"2011","unstructured":"Bahl A, Hoefeler H, Duran I, Hechmati G, Garzon-Rodriguez C, L\u00fcftner D, et al. Health resource utilization (HRU) associated with skeletal-related events (SREs) in patients with bone metastases (BM): results of a prospective multinational observational study. J Clin Oncol. 2011;29:e16523 (suppl; abstr).","journal-title":"J Clin Oncol."},{"issue":"7","key":"1077_CR18","doi-asserted-by":"crossref","first-page":"A455","DOI":"10.1016\/j.jval.2011.08.1216","volume":"14","author":"G Hechmati","year":"2011","unstructured":"Hechmati G, Cure S, Gou\u00e9po A, Hoefeler H, Lorusso V, L\u00fcftner D, et al. Cost of skeletal-related events (SREs) in patients with bone metastases to solid tumours based on the health resource utilisation (HRU) collected in a prospective European multinational observational study. Value Health. 2011;14(7):A455 (PCN115).","journal-title":"Value Health."},{"key":"1077_CR19","unstructured":"Oblikue Consulting. eSalud\u2014informaci\u00f3n econ\u00f3mica del sector sanitario. Base de datos de costes sanitarios. 2012. http:\/\/www.oblikue.com\/bddcostes . Accessed 30 May 2012."},{"issue":"4","key":"1077_CR20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpainsymman.2007.01.001","volume":"33","author":"J Gralow","year":"2007","unstructured":"Gralow J, Tripathy D. Managing metastatic bone pain: the role of bisphosphonates. J Pain Symptom Manage. 2007;33(4):462\u201372.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"1077_CR21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","volume":"129","author":"M Yong","year":"2011","unstructured":"Yong M, Jensen A\u00d6, Jacobsen JB, N\u00f8rgaard M, Fryzek JP, S\u00f8rensen HT. Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999\u20132007). Breast Cancer Res Treat. 2011;129(2):495\u2013503.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1077_CR22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.juro.2010.03.034","volume":"184","author":"M Norgaard","year":"2010","unstructured":"Norgaard M, Jensen A\u00d8, Jacobsen JB, Cetin K, Fryzek JP, S\u00f8rensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol. 2010;184(1):162\u20137.","journal-title":"J Urol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-013-1077-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-013-1077-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-013-1077-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T17:12:34Z","timestamp":1563642754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-013-1077-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,13]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s12094-013-1077-2","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,13]]}}}